These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 4230957

  • 21. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 22. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A, Johnston PA, Morgan AG, Davison AM, Burden RP.
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [Abstract] [Full Text] [Related]

  • 23. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO.
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [Abstract] [Full Text] [Related]

  • 24. Relationship between autonomic function and plasma fibrinogen, viscosity, and elements of fibrinolytic activity in diabetic nephropathy.
    Weinrauch LA, Gleason RE, Keough J, D'Elia JA.
    Am J Hypertens; 1997 Apr; 10(4 Pt 1):454-61. PubMed ID: 9128213
    [Abstract] [Full Text] [Related]

  • 25. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 26. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM.
    Am J Cardiol; 2006 May 01; 97(9):1287-91. PubMed ID: 16635597
    [Abstract] [Full Text] [Related]

  • 27. Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.
    Wakabayashi I, Masuda H.
    Thromb Res; 2007 May 01; 121(1):95-102. PubMed ID: 17439823
    [Abstract] [Full Text] [Related]

  • 28. Arterio-venous differences in the components of the fibrinolytic enzyme system.
    Ogston D, Ogston CM, Bennett NB.
    Thromb Diath Haemorrh; 1966 Jul 31; 16(1):32-7. PubMed ID: 4229628
    [No Abstract] [Full Text] [Related]

  • 29. [Non-enzymatic fibrinolysis in patients with hypertensive disease].
    Panchenko VM, Ol'khin VA, Kudriashov BA, Liapina LA.
    Kardiologiia; 1973 Aug 31; 13(8):83-8. PubMed ID: 4272779
    [No Abstract] [Full Text] [Related]

  • 30. The fibrinolytic enzyme system in hypertension.
    Bennett B, Ogston D, Crawford GP, Douglas AS.
    J Clin Pathol; 1973 May 31; 26(5):351-3. PubMed ID: 4714959
    [Abstract] [Full Text] [Related]

  • 31. [Fibrinolytic activity of the blood in the human coronary vessels].
    Chazov EI, Andreenko GV, Liutova LV, Mazaev AV, Sargin KE.
    Kardiologiia; 1974 Apr 31; 14(4):12-8. PubMed ID: 4275939
    [No Abstract] [Full Text] [Related]

  • 32. [Changes in the fibrinolytic system of the blood in patients with hypertension with coronary arteriosclerosis and circulatory insufficiency].
    Aslanian NL, Dolabchian ZL, Shukhian VM, Demirchian AKh, Khachaturova IA.
    Kardiologiia; 1972 Jul 31; 12(7):106-9. PubMed ID: 4670631
    [No Abstract] [Full Text] [Related]

  • 33. Fibrinolytic activity of blood in rheumatic fever.
    Goryachkin YK.
    Fed Proc Transl Suppl; 1965 Jul 31; 24(5):845-6. PubMed ID: 4220954
    [No Abstract] [Full Text] [Related]

  • 34. [Indications for using a new magnetotherapeutic method in arterial hypertension].
    Orlov LL, Alekseeva NP, Galuza GI, Memetov KA, Berlin IuV.
    Sov Med; 1991 Jul 31; (8):23-4. PubMed ID: 1763352
    [No Abstract] [Full Text] [Related]

  • 35. [The fibrinolytic enzyme system in children with acute glomerulonephritis].
    Goldschmidt B, Marosvári I.
    Klin Wochenschr; 1968 Apr 15; 46(8):421-4. PubMed ID: 4234844
    [No Abstract] [Full Text] [Related]

  • 36. [Endogenous and exogenous fibrinolysis (with reference to the fibrinolytic activity of the kidney and blood cell constituents)].
    Abe T, Kazama M.
    Saishin Igaku; 1966 Feb 15; 21(2):260-73. PubMed ID: 4226029
    [No Abstract] [Full Text] [Related]

  • 37. [Factors of the fibrinolytic system in liver diseases].
    van de Loo J, Schmiesing G.
    Thromb Diath Haemorrh; 1965 Nov 15; 14(3-4):580-91. PubMed ID: 4222263
    [No Abstract] [Full Text] [Related]

  • 38. Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney.
    Niewiarowski S, Prokopowicz J, Poplawski A, Worowski K.
    Experientia; 1964 Feb 15; 20(2):101-3. PubMed ID: 5852151
    [No Abstract] [Full Text] [Related]

  • 39. [Physiopathology and prognosis of hypertension].
    Omae T.
    Nihon Naika Gakkai Zasshi; 1984 Feb 15; 73(2):183-5. PubMed ID: 6726046
    [No Abstract] [Full Text] [Related]

  • 40. Depressed endogenous fibrinolytic activity in essential hypertension.
    Tsapogas MJ, Peabody RA, Wu K, Devaraj KT, Eckert C.
    J Cardiovasc Surg (Torino); 1973 Feb 15; Spec No():626-9. PubMed ID: 4806924
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.